Open original FDA record ↗Recall record
- FDA identifier
- Z-1818-2022
- Company in FDA record
- DICOM Grid, Inc. d/b/a Ambra Health
- FDA classification date
- Sep 27, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A race condition between the storage system and services database has the potential to revert edits made to patient information upon first ingestion of a study.
Source facts
- Action
- The firm distributed an Urgent Medical Device Recall Notice dated June 23, 2022, by email to affected customers. The firm informed customers that a race condition was identified between Ambra's storage system and the serivces database which has the potential to revert edits made to patient health information upon first ingestion of a study. This could lead to a possibility that incorrect patient ifnormation is presented to the physician, which would impact the decision making in regard to patient care. Customers are asked to advise all users of the system of this issue, request a patch from Ambra to be enabled on your system, and wait until all images for a given study are ingested before manually editing patient health information in the study. Ambra's actions include the deployment of a patch that is acting as a temporary fix until a software update can be deployed to all customers, which will prevent the issue from occurring in the future.
- Initiated
- 2022-06-23
- Root cause
- Software design
- Distribution
- Domestic: AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, DC, & PR.
- Recall number
- Z-1818-2022
- Recall status
- Open, Classified
- CDRH record ID
- 195945
- FDA classified
- 2022-09-27
- Recall event number
- 90817